{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:50:53Z","timestamp":1782208253175,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12325-026-03585-5","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:28:54Z","timestamp":1776497334000},"page":"2949-2960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Lived Experiences of Adult Continuous Glucose Monitor Users with Type 1 Diabetes with Recurrent Severe Hypoglycemic Events and Impaired Awareness of Hypoglycemia: A Qualitative Study"],"prefix":"10.1007","volume":"43","author":[{"given":"Adriana","family":"Boateng-Kuffour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin S.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keval","family":"Chandarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilee M.","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Polonsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"1","key":"3585_CR1","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbj\u00f6rnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3(1):17016.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3585_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4093\/dmj.2024.0130","volume":"49","author":"W Fan","year":"2025","unstructured":"Fan W, Deng C, Xu R, Liu Z, Leslie RD, Zhou Z, et al. Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabet Metab J. 2025;49(2):235\u201351.","journal-title":"Diabet Metab J"},{"issue":"3","key":"3585_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2337\/diaclin.24.3.115","volume":"24","author":"VJ Briscoe","year":"2006","unstructured":"Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology,and management. Clin Diabet. 2006;24(3):115\u201321.","journal-title":"Clin Diabet"},{"issue":"8","key":"3585_CR4","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2337\/dc16-2723","volume":"40","author":"RA Gubitosi-Klug","year":"2017","unstructured":"Gubitosi-Klug RA, Braffett BH, White NH, Sherwin RS, Service FJ, Lachin JM, et al. Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT\/EDIC study. Diabetes Care. 2017;40(8):1010\u20136.","journal-title":"Diabetes Care"},{"issue":"5","key":"3585_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00592-015-0713-4","volume":"52","author":"CB Giorda","year":"2015","unstructured":"HYPOS-1 Study Group of AMD, Giorda CB, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, et al. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. Acta Diabetol. 2015;52(5):845\u201353.","journal-title":"Acta Diabetol"},{"issue":"7","key":"3585_CR6","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i7.912","volume":"6","author":"I Mart\u00edn-Tim\u00f3n","year":"2015","unstructured":"Mart\u00edn-Tim\u00f3n I. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes. 2015;6(7):912.","journal-title":"World J Diabetes"},{"issue":"1","key":"3585_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2337\/dc23-1001","volume":"47","author":"I Hernar","year":"2024","unstructured":"Hernar I, Cooper JG, Nilsen RM, Skinner TC, Strandberg RB, Iversen MM, et al. Diabetes distress and associations with demographic and clinical variables: a nationwide population-based registry study of 10,186 adults with type 1 diabetes in Norway. Diabetes Care. 2024;47(1):126\u201331.","journal-title":"Diabetes Care"},{"issue":"6","key":"3585_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2337\/dc23-1765","volume":"47","author":"JL Sherr","year":"2024","unstructured":"Sherr JL, Laffel LM, Liu J, Wolf W, Bispham J, Chapman KS, et al. Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey. Diabetes Care. 2024;47(6):941\u20137.","journal-title":"Diabetes Care"},{"key":"3585_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107988","volume":"160","author":"V Suteau","year":"2020","unstructured":"Suteau V, Saulnier PJ, Wargny M, Gonder-Frederick L, Gand E, Chaillous L, et al. Association between sleep disturbances, fear of hypoglycemia and psychological well-being in adults with Type 1 diabetes mellitus, data from cross-sectional VARDIA study. Diabetes Res Clin Pract. 2020;160:107988.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"3585_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jdiacomp.2015.01.012","volume":"29","author":"L Fisher","year":"2015","unstructured":"Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL, et al. Understanding the sources of diabetes distress in adults with Type 1 diabetes. J Diabetes Complicat. 2015;29(4):572\u20137.","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"3585_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jdiacomp.2016.12.015","volume":"31","author":"P Martyn-Nemeth","year":"2017","unstructured":"Martyn-Nemeth P, Quinn L, Penckofer S, Park C, Hofer V, Burke L. Fear of hypoglycemia: influence on glycemic variability and self-management behavior in young adults with Type 1 diabetes. J Diabetes Complicat. 2017;31(4):735\u201341.","journal-title":"J Diabetes Complicat"},{"issue":"8","key":"3585_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/1054773818774702","volume":"28","author":"P Martyn-Nemeth","year":"2019","unstructured":"Martyn-Nemeth P, Duffecy J, Fritschi C, Quinn L. Challenges imposed by hypoglycemia in adults with Type 1 diabetes. Clin Nurs Res. 2019;28(8):947\u201367.","journal-title":"Clin Nurs Res"},{"issue":"3","key":"3585_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11136-005-1624-6","volume":"15","author":"M Brod","year":"2006","unstructured":"Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res. 2006;15(3):481\u201391.","journal-title":"Qual Life Res"},{"key":"3585_CR14","doi-asserted-by":"crossref","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589\u2013625.","DOI":"10.2337\/dci21-0043"},{"issue":"5","key":"3585_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/dc18-1426","volume":"42","author":"UM Hansen","year":"2019","unstructured":"Hansen UM, Skinner T, Olesen K, Willaing I. Diabetes distress, intentional hyperglycemia at work, and glycemic control among workers with type 1 diabetes. Diabetes Care. 2019;42(5):797\u2013803.","journal-title":"Diabetes Care"},{"key":"3585_CR16","unstructured":"Mouri Mi, Badireddy M. Hyperglycemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 3]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430900\/."},{"key":"3585_CR17","doi-asserted-by":"crossref","unstructured":"Pettus JH, Zhou FL, Shepherd L, Preblick R, Hunt PR, Paranjape S, et al. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. Adult patients with type 1 diabetes: a real-world study. Diabetes Care. 2019;42(12):2220\u20137.","DOI":"10.2337\/dc19-0830"},{"issue":"11","key":"3585_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrendo.2012.154","volume":"8","author":"L Ringholm","year":"2012","unstructured":"Ringholm L, Mathiesen ER, Kelstrup L, Damm P. Managing type 1 diabetes mellitus in pregnancy\u2014from planning to breastfeeding. Nat Rev Endocrinol. 2012;8(11):659\u201367.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"3585_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/dc15-0090","volume":"38","author":"P Choudhary","year":"2015","unstructured":"Choudhary P, Rickels MR, Senior PA, Vantyghem MC, Maffi P, Kay TW, et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care. 2015;38(6):1016\u201329.","journal-title":"Diabetes Care"},{"issue":"7","key":"3585_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2337\/diacare.17.7.697","volume":"17","author":"AE Gold","year":"1994","unstructured":"Gold AE, Macleod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697\u2013703.","journal-title":"Diabetes Care"},{"issue":"2","key":"3585_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2337\/dc24-1474","volume":"48","author":"LM Laffel","year":"2025","unstructured":"Laffel LM, Sherr JL, Liu J, Wolf WA, Bispham J, Chapman KS, et al. Limitations in achieving glycemic targets from CGM data and persistence of severe hypoglycemia in adults with type 1 diabetes regardless of insulin delivery method. Diabetes Care. 2025;48(2):273\u20138.","journal-title":"Diabetes Care"},{"issue":"3","key":"3585_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00592-014-0694-8","volume":"52","author":"T Anderbro","year":"2015","unstructured":"Anderbro T, Gonder-Frederick L, Bolinder J, Lins PE, Wredling R, Moberg E, et al. Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors. Acta Diabetol. 2015;52(3):581\u20139.","journal-title":"Acta Diabetol"},{"issue":"7","key":"3585_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.numecd.2019.04.009","volume":"29","author":"MC Rossi","year":"2019","unstructured":"Rossi MC, Nicolucci A, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, et al. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. Nutr Metab Cardiovasc Dis. 2019;29(7):736\u201343.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"3585_CR24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2337\/diacare.26.4.1106","volume":"26","author":"HV J\u00f8rgensen","year":"2003","unstructured":"J\u00f8rgensen HV, Pedersen-Bjergaard U, Rasmussen \u00c5K, Borch-Johnsen K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care. 2003;26(4):1106\u20139.","journal-title":"Diabetes Care"},{"issue":"1","key":"3585_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14944","volume":"40","author":"J Speight","year":"2023","unstructured":"Speight J, Choudhary P, Wilmot EG, Hendrieckx C, Forde H, Cheung WY, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review. Diabet Med. 2023;40(1):e14944.","journal-title":"Diabet Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03585-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:22:38Z","timestamp":1782206558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03585-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3585"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03585-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adriana Boateng-Kuffour, Keval Chandarana, and Liang Chen are employees of Vertex Pharmaceutical, Inc. and may own stock or stock options in that company. Huyen T. Nguyen, Katherine S. Chapman, and Emilee M. Cornelius\u00a0are employees of T1D Exchange, which received funding from Vertex Pharmaceuticals Incorporated for conducting this study. Caitlin S. Kelly is currently employed as a Medical Writer II at Syneos Health, but contributed to this work during prior employment at T1D Exchange, Inc. Wendy A. Wolf was employed by T1D Exchange at the time the study was conducted, but is no longer an employee of T1D Exchange. William H. Polonsky received consulting fees from Vertex Pharmaceuticals Incorporated for conducting this study. William H. Polonsky received grants from Abbott Diabetes Care, Eli Lilly and Dexcom, consulting fees from Vertex, Dexcom, Mannkind, Roche, Abbott Diabetes Care, Sanofi, Ascensia, and Insulet, and lecture fees from Sanofi and Roche; all of which are unrelated to his involvement in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was reviewed and approved by Western-Copernicus Group (WCG) IRB and conformed to ethical standards outlined in the US Federal Policy for the Protection of Human Subjects and current guidelines for Good Pharmacoepidemiology Practices (GPP). Respondents were recruited between June and August 2023 from the T1D Exchange Registry, which is an online, longitudinal study of pwT1D who consented to be contacted for additional T1D-related research opportunities, such as the present study. Participants were informed that their responses may be published in a medical journal, and written informed consent to publish was obtained from participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}